Determining the rapidity with which exogenous P suppresses daytime LH (GnRH) pulse frequency in women during the follicular phase of the menstrual cycle.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Progesterone (Primary)
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 14 Oct 2020 Biomarkers information updated
- 05 Jun 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 05 Jun 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.